参考文献

［1］胡盛寿，高润霖，刘力生，等. 《中国心血管病报告2018》概要［J］. 中国循环杂志，2019，34（3）：209，220.

［2］Ponikowski P, Voors A A, Anker S D, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC［J］. Eur J Heart Fail, 2016, 18(8): 891-975.(https://www.daowen.com)

［3］O’Meara E, Mcdonald M, Chan M, et al. CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis［J］. Can J Cardiol, 2020, 36(2): 159-169.

（张　黎　王　红）